Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs

BackgroundThere is renewed acknowledgement that targeting gametocytes is essential for malaria control and elimination efforts. Simple mathematical models were fitted to data from clinical trials in order to determine the mean gametocyte circulation time and duration of gametocyte carriage in treated malaria patients.MethodsData were used from clinical trials from East Africa. The first trial compared non-artemisinin combination therapy (non-ACT: sulphadoxine-pyrimethamine (SP) plus amodiaquine) and artemisinin-based combination therapy (ACT: SP plus artesunate (AS) or artemether-lumefantrine). The second trial compared ACT (SP+AS) with ACT in combination with a single dose of primaquine (ACT-PQ: SP+AS+PQ). Mature gametocytes were quantified in peripheral blood samples by nucleic acid sequence based amplification. A simple deterministic compartmental model was fitted to gametocyte densities to estimate the circulation time per gametocyte; a similar model was fitted to gametocyte prevalences to estimate the duration of gametocyte carriage after efficacious treatment.ResultsThe mean circulation time of gametocytes was 4.6-6.5 days. After non-ACT treatment, patients were estimated to carry gametocytes for an average of 55 days (95% CI 28.7 - 107.7). ACT reduced the duration of gametocyte carriage fourfold to 13.4 days (95% CI 10.2-17.5). Addition of PQ to ACT resulted in a further fourfold reduction of the duration of gametocyte carriage.ConclusionsThese findings confirm previous estimates of the circulation time of gametocytes, but indicate a much longer duration of (low density) gametocyte carriage after apparently successful clearance of asexual parasites. ACT shortened the period of gametocyte carriage considerably, and had the most pronounced effect on mature gametocytes when combined with PQ.

[1]  H. Ferguson,et al.  Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. , 2005, International journal for parasitology.

[2]  A. Muñoz,et al.  Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. , 2002, American journal of epidemiology.

[3]  Petra Schneider,et al.  Real-Time Nucleic Acid Sequence-Based Amplification Is More Convenient than Real-Time PCR for Quantification of Plasmodium falciparum , 2005, Journal of Clinical Microbiology.

[4]  J. Simpson,et al.  Population pharmacokinetics of artesunate and amodiaquine in African children , 2009, Malaria Journal.

[5]  Teun Bousema,et al.  Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials , 2008, Malaria Journal.

[6]  B. Ngasala,et al.  Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania. , 2007, The Journal of infectious diseases.

[7]  A. Ghani,et al.  Rapid Assessment of Malaria Transmission Using Age-Specific Sero-Conversion Rates , 2009, PloS one.

[8]  S. E. Reece,et al.  Gametocytes: insights gained during a decade of molecular monitoring , 2008, Trends in parasitology.

[9]  A. Ghani,et al.  Modelling the Impact of Artemisinin Combination Therapy and Long-Acting Treatments on Malaria Transmission Intensity , 2008, PLoS medicine.

[10]  C. Drakeley,et al.  Increased Plasmodium falciparum gametocyte production in mixed infections with P. malariae. , 2008, The American journal of tropical medicine and hygiene.

[11]  G. Butcher.  Antimalarial drugs and the mosquito transmission of Plasmodium. , 1997, International journal for parasitology.

[12]  N. White.  The role of anti-malarial drugs in eliminating malaria , 2008, Malaria Journal.

[13]  Nirbhay Kumar,et al.  Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu onPlasmodium falciparum , 2004, Parasitology Research.

[14]  R. Sinden,et al.  Plasmodium falciparum gametocytes: their longevity and infectivity , 1977, Parasitology.

[15]  A. Gunders.  The effect of a single dose of pyrimethamine and primaquine in combination upon gametocytes and sporogony of Laverania falcipara (Plasmodium falciparum) in Liberia. , 1961, Bulletin of the World Health Organization.

[16]  R. Sauerwein.  Malaria transmission-blocking vaccines: the bonus of effective malaria control. , 2007, Microbes and infection.

[17]  R. Sauerwein,et al.  Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. , 2007, The American journal of tropical medicine and hygiene.

[18]  M. D. Young,et al.  The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine- and pyrimethamine-treated cases. , 1956, American journal of hygiene.

[19]  Petra Schneider,et al.  Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. , 2006, The Journal of infectious diseases.

[20]  C. Drakeley,et al.  Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. , 2001, The Journal of infectious diseases.

[21]  Paul Garner,et al.  Artemisinin-based combination therapy for treating uncomplicated malaria. , 2009, The Cochrane database of systematic reviews.

[22]  David L. Smith,et al.  Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations , 2009, Malaria Journal.

[23]  Kamolrat Silamut,et al.  Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2 , 2005, PLoS medicine.

[24]  C. Drakeley,et al.  Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya , 2004, Malaria Journal.

[25]  C. Drakeley,et al.  The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. , 2006, Trends in parasitology.

[26]  T. Bousema,et al.  Primaquine Clears Submicroscopic Plasmodium falciparum Gametocytes that Persist after Treatment with Sulphadoxine-Pyrimethamine and Artesunate , 2007, PloS one.

[27]  Nicholas J. White,et al.  Activities of Artesunate and Primaquine against Asexual- and Sexual-Stage Parasites in Falciparum Malaria , 2004, Antimicrobial Agents and Chemotherapy.

[28]  R. Moreira,et al.  Primaquine revisited six decades after its discovery. , 2009, European journal of medicinal chemistry.

[29]  M. Edstein,et al.  Lack of sex effect on the pharmacokinetics of primaquine. , 2006, The American journal of tropical medicine and hygiene.

[30]  M. Dgedge,et al.  Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique. , 1995, The American journal of tropical medicine and hygiene.

[31]  D. Arnot,et al.  Unstable malaria in Sudan: the influence of the dry season. Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[32]  A. Talman,et al.  Gametocytogenesis : the puberty of Plasmodium falciparum , 2004, Malaria Journal.

[33]  H. Babiker,et al.  Dynamics of gametocytes among Plasmodium falciparum clones in natural infections in an area of highly seasonal transmission. , 2002, The Journal of infectious diseases.

[34]  J. Sattabongkot,et al.  Transmission-Blocking Activities of Quinine, Primaquine, and Artesunate , 2006, Antimicrobial Agents and Chemotherapy.

[35]  A. Lensen,et al.  Plasmodium falciparum: infectivity of cultured, synchronized gametocytes to mosquitoes. , 1999, Experimental parasitology.

[36]  L. Molineaux,et al.  The Garki project: Research on the epidemiology and control of malaria in the Sudan savanna of West Africa , 1980 .

[37]  Hussien O. AlKadi,et al.  Antimalarial Drug Toxicity: A Review , 2007, Chemotherapy.

[38]  C. Drakeley,et al.  Reduction of Malaria Transmission to Anopheles Mosquitoes with a Six-Dose Regimen of Co-Artemether , 2005, PLoS medicine.

[39]  T. Bousema,et al.  Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission , 2009, PloS one.

[40]  K Dietz,et al.  Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[41]  Petra Schneider,et al.  Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. , 2004, Molecular and biochemical parasitology.

[42]  N. White,et al.  Qinghaosu (Artemisinin): The Price of Success , 2008, Science.

[43]  K. Mendis,et al.  Malaria transmission-blocking vaccines—how can their development be supported? , 2000, Nature Medicine.

[44]  H. Babiker,et al.  A Randomized Open-Label Trial of Artesunate- Sulfadoxine-Pyrimethamine with or without Primaquine for Elimination of Sub-Microscopic P. falciparum Parasitaemia and Gametocyte Carriage in Eastern Sudan , 2007, PloS one.